Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website


Exelixis reported $327.6M in Current Liabilities for its fiscal quarter ending in March of 2023.

Current Liabilities Change
Acadia Pharmaceuticals ACAD:US USD 224.3M 98.67M
Agios Pharmaceuticals AGIO:US USD 45.11M 17.52M
Akebia Therapeutics AKBA:US USD 82.94M 41.81M
Amgen AMGN:US USD 14.22B 1.47B
AstraZeneca AZN:LN USD 24.86B 1.43B
Bayer BAYN:GR EUR 34.39B 693M
BioMarin Pharmaceutical BMRN:US USD 598.23M 9.35M
Bluebird Bio BLUE:US USD 115.93M 12.3M
Cytokinetics CYTK:US USD 75.22M 9.4M
Eisai 4523:JP JPY 298.94B 14.73B
Eli Lilly LLY:US USD 16.01B 1.13B
Esperion Therapeutics ESPR:US USD 95.49M 3.18M
Exelixis EXEL:US USD 327.6M 3.24M
Genmab GEN:DC DKK 1.96B 132M
Glaxosmithkline GSK:US GBP 20.7B 2.11B
Immunogen IMGN:US USD 101.63M 20.23M
Incyte Corp INCY:US USD 1.01B 150.97M
Ionis Pharmaceuticals IONS:US USD 259.22M 52.34M
MacroGenics MGNX:US USD 45.61M 3M
Mirati Therapeutics MRTX:US USD 124.6M 34.85M
Moderna Inc MRNA:US USD 3.5B 1.42B
Nektar Therapeutics NKTR:US USD 59.88M 8.32M
Neurocrine Biosciences NBIX:US USD 374.1M 163.6M
Novartis NOVN:VX USD 30.55B 1.89B
Puma Biotechnology PBYI:US USD 48.19M 29.3M
Seattle Genetics SGEN:US USD 713.23M 105.18M
Takeda 4502:JP JPY 2.48T 245.13B
Ultragenyx Pharmaceutical RARE:US USD 218.18M 43.03M
Xencor XNCR:US USD 65.06M 1.21M